News

The US has given the green light to a new COVID-19 vaccine developed by Moderna, but with certain restrictions on its use.
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a re ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...
The Wall Street Journal: FDA Punts On Major Covid-19 Vaccine Decision After Ouster Of Top Official Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 ...
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.